People Briefs: Encision, Solta, Chembio, Accuray, Devon and FDA
This article was originally published in The Gray Sheet
Executive Summary
Encision CEO Fred Perner dead at 59. Solta Medical CEO resigns. Chembio president and CEO announces he will retire in May. FDA gains permanent regulatory affairs chief. More people news.
You may also be interested in...
Valeant Adds Energy To Its Aesthetics Offerings With Solta Medical
Valeant Pharmaceuticals says it will buy energy-based aesthetics device firm Solta Medical for about $250 million, to expand the breadth of its offerings to dermatologists and plastic surgeons.
People Briefs: New CEO At Hologic; Departures At MDMA
Hologic appoints former Stryker CEO MacMillan president and CEO. Two staffers leave MDMA for device firms. More people briefs.
Bayer Buys Essure Contraceptive-Maker Conceptus For $1.1 Billion
The acquisition will add a popular nonsurgical, permanent birth control device to Bayer’s line of contraceptive pharmaceuticals and women’s health products.